The purpose of this study is to evaluate the safety and efficacy of Epiduo® (adapalene and
benzoyl peroxide) Gel 0.1%/2.5% administered once daily for up to 12 weeks in subjects 9 to
11 years of age with acne vulgaris.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma Galderma R&D
Treatments:
Adapalene Adapalene, Benzoyl Peroxide Drug Combination Benzoyl Peroxide